Antimicrobial resistance patterns and difficult-to-treat resistance in uropathogens among diabetic and non-diabetic patients: a cross-sectional study.
- 1Department of Medical Laboratory and Life Sciences, Faculty of Medicine, Parul Institute of Allied and Healthcare Sciences, Parul University, Vadodara, Gujarat, 391760, India. [email protected].
- 2Department of Medical Laboratory and Life Sciences, Faculty of Medicine, Parul Institute of Allied and Healthcare Sciences, Parul University, Vadodara, Gujarat, 391760, India.
- 3Parul Institute of Allied and Healthcare Sciences, Faculty of Medicine, Parul University, Vadodara, Gujarat, 391760, India.
Abstract
Background
While antimicrobial resistance (AMR) is a global challenge, data comparing Difficult-to-Treat Resistance (DTR) in diabetic versus non-diabetic urinary tract infection (UTI) patients is scarce. This study uniquely evaluates DTR and first-line resistance patterns to inform targeted empirical treatment strategies for these distinct patient cohorts.Methods
A prospective observational cross-sectional study was conducted from August 2021 to January 2024, at a tertiary care teaching hospital in Vadodara, Gujarat, India. During the period, 2408 patients with symptoms of UTI were screened for urine culture and sensitivity, of which 954 individuals tested positive for UTIs.Result
Of the 2,408 symptomatic patients screened, 954 (39.61%) tested positive. The within-group UTI positivity rate was 27.4% (280/1,023) among diabetic patients and 48.7% (674/1,385) among non-diabetic patients. Among the isolated uropathogens, Escherichia coli (E. coli) (56.78%, 62.90%) was the predominant organism followed by Pseudomonas aeruginosa (P. aeruginosa) (13.57%, 5.78%) and Klebsiella spp. (13.21%, 17.35%) in diabetic and non-diabetic respectively. Among all the isolated uropathogen tetracycline (81.25%) and penicillin (71.86%) groups of antibiotics showed high resistance in diabetic patients, whereas fluoroquinolones had highest resistance in non-diabetic with 67.59%. However, the carbapenem, phosphonic and nitrofuran group of antibiotics showed least resistance in both diabetic and non-diabetic populations. Among all the antimicrobial drugs tested in our study, the first line of drugs was further analyzed, and P. aeruginosa had the highest DTR in both diabetic and non-diabetic individuals.Conclusion
Despite lower culture positivity rates among diabetic patients, diabetic UTI cases demonstrated substantially higher AMR burden and DTR compared to non-diabetics. P. aeruginosa showed highest DTR prevalence. Penicillin and tetracycline resistance were markedly elevated in diabetic UTIs, while nitrofurantoin and fosfomycin maintained high effectiveness in both groups. These findings emphasize that diabetes is strongly associated with greater therapeutic complexity and multidrug resistance burden, necessitating resistance-guided empirical therapy and regional antibiogram surveillance for optimal UTI management.
Related
- Beyond the patient: Inanimate objects as reservoirs for potential pathogenic bacteria and antimicrobial resistance patterns in hospital wards, a cross-sectional study from Goba Referral Hospital.
- Antimicrobial Resistance Patterns Among Gram-Negative Bacterial Isolates Recovered from Tracheal Aspirate Cultures in Türkiye: A Systematic Review and Meta-Analysis
- Phenotypic Antimicrobial Resistance Patterns in E. coli, Salmonella, and Enterobacter Species Isolated from Broiler Chicken Meat in Mzimba, Malawi: Insights from the Multiple Antibiotic Resistance Index.
- Multi-drug resistance and multiple antibiotic resistance index of uropathogens in diabetic and non-diabetic patients with urinary tract infections
- Microbiological Profile and Antimicrobial Resistance Patterns Among Orthopedic Patients at a Tertiary Care Centre in Uttarakhand, India
BibTeX
@article{priyadarshini2026antimicrobial,
title = {{Antimicrobial resistance patterns and difficult-to-treat resistance in uropathogens among diabetic and non-diabetic patients: a cross-sectional study.}},
author = {Ankita Priyadarshini and Priyal Kalola and Hemantkumar Patadia},
journal = {BMC infectious diseases},
year = {2026},
month = jul,
doi = {10.1186/s12879-026-13969-1},
url = {https://europepmc.org/article/MED/42902228},
note = {CC BY-NC-ND},
}
RIS
TY - JOUR
TI - Antimicrobial resistance patterns and difficult-to-treat resistance in uropathogens among diabetic and non-diabetic patients: a cross-sectional study.
AU - Ankita Priyadarshini
AU - Priyal Kalola
AU - Hemantkumar Patadia
PY - 2026
DA - 2026/07/01
JO - BMC infectious diseases
DO - 10.1186/s12879-026-13969-1
UR - https://europepmc.org/article/MED/42902228
AB - Background While antimicrobial resistance (AMR) is a global challenge, data comparing Difficult-to-Treat Resistance (DTR) in diabetic versus non-diabetic urinary tract infection (UTI) patients is scarce. This study uniquely evaluates DTR and first-line resistance patterns to inform targeted empirical treatment strategies for these distinct patient cohorts.Methods A prospective observational cross-sectional study was conducted from August 2021 to January 2024, at a tertiary care teaching hospital in Vadodara, Gujarat, India. During the period, 2408 patients with symptoms of UTI were screened for urine culture and sensitivity, of which 954 individuals tested positive for UTIs.Result Of the 2,408 symptomatic patients screened, 954 (39.61%) tested positive. The within-group UTI positivity rate was 27.4% (280/1,023) among diabetic patients and 48.7% (674/1,385) among non-diabetic patients. Among the isolated uropathogens, Escherichia coli (E. coli) (56.78%, 62.90%) was the predominant organism followed by Pseudomonas aeruginosa (P. aeruginosa) (13.57%, 5.78%) and Klebsiella spp. (13.21%, 17.35%) in diabetic and non-diabetic respectively. Among all the isolated uropathogen tetracycline (81.25%) and penicillin (71.86%) groups of antibiotics showed high resistance in diabetic patients, whereas fluoroquinolones had highest resistance in non-diabetic with 67.59%. However, the carbapenem, phosphonic and nitrofuran group of antibiotics showed least resistance in both diabetic and non-diabetic populations. Among all the antimicrobial drugs tested in our study, the first line of drugs was further analyzed, and P. aeruginosa had the highest DTR in both diabetic and non-diabetic individuals.Conclusion Despite lower culture positivity rates among diabetic patients, diabetic UTI cases demonstrated substantially higher AMR burden and DTR compared to non-diabetics. P. aeruginosa showed highest DTR prevalence. Penicillin and tetracycline resistance were markedly elevated in diabetic UTIs, while nitrofurantoin and fosfomycin maintained high effectiveness in both groups. These findings emphasize that diabetes is strongly associated with greater therapeutic complexity and multidrug resistance burden, necessitating resistance-guided empirical therapy and regional antibiogram surveillance for optimal UTI management.
SN - 1471-2334
ER -